TRG is crucial because it provides insights into the efficacy of neoadjuvant treatments. By assessing how much of the tumor has regressed, oncologists can tailor subsequent therapeutic strategies more effectively. Furthermore, TRG has prognostic value; a better tumor response usually correlates with improved survival rates and lower recurrence risks.
